Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma

PURPOSE: To elucidate the use of Ripasudil in patients of advanced glaucoma on maximally tolerated medical therapy who could not be offered the option of surgery due to the global pandemic lockdown. MATERIALS AND METHODS: Only patients with primary open angle glaucoma (POAG), who had a cup-disc rati...

Descripción completa

Detalles Bibliográficos
Autores principales: Naik, Mayuresh, Kapur, Monika, Gupta, VishnuSwarup, Sethi, HarinderSingh, Srivastava, Kartikeya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238538/
https://www.ncbi.nlm.nih.gov/pubmed/34194222
http://dx.doi.org/10.2147/OPTH.S318897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238538/
https://www.ncbi.nlm.nih.gov/pubmed/34194222
http://dx.doi.org/10.2147/OPTH.S318897

Ejemplares similares